uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Begedina
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/004144
ATC code
L04AA35
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of graft-versus-host disease.
MeSH:
Graft vs Host Disease;Hematopoietic Stem Cell Transplantation
Group:
Immunosuppressants
Active substances
begelomab
Marketing Authorisation Holder
Adienne S.r.l. S.U.
MAH
Begedina | uMedical